+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain



Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain



Journal of Biological Chemistry 266(21): 13828-13833



Ligand-induced oligomerization is a universal phenomenon among growth factor receptors. Although the mechanism involved is yet to be defined, much evidence indicates that receptor oligomerization plays a crucial role in receptor activation and signal transduction. Here we show that epidermal growth factor (EGF) is able to stimulate the oligomerization of a recombinant, soluble, extracellular ligand-binding domain of EGF receptor. Covalent cross-linking experiments, analysis by sodium dodecyl sulfate-gel electrophoresis, size exclusion chromatography, and electron microscopy demonstrate that receptor dimers, trimers and larger multimers are formed in response to EGF. This establishes that receptor oligomerization is an intrinsic property of the extracellular ligand-binding domain of EGF receptor. Ligand-induced conformational change in the extracellular domain will stimulate receptor-receptor interactions. This may bring about the allosteric change involved in signal transduction from the extracellular domain across the plasma membrane, resulting in the activation of the cytoplasmic kinase domain. Electron microscopic images of individual extracellular ligand-binding domains appear as clusters of four similarly-sized stain-excluding areas arranged around a central, relatively less stain-excluded area. This suggests that the extracellular ligand-binding domain is structurally composed of four separate domains.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040038378

Download citation: RISBibTeXText

PMID: 1856216


Related references

EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain. Journal of Biological Chemistry 266(32): 22035-22043, 1991

Polymorphism of the epidermal growth factor receptor extracellular ligand binding domain: the dimer interface depends on domain stabilization. Biochemistry 50(12): 2144-2156, 2011

Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor. Journal of Biochemistry 122(1): 116-121, 1997

Dimerization of the extracellular domain of granuloycte-colony stimulating factor receptor by ligand binding: a monovalent ligand induces 2:2 complexes. Biochemistry 35(15): 4886-4896, 1996

Extracellular domain of granulocyte-colony stimulating factor receptor. Interaction with its ligand and identification of a domain in close proximity of ligand-binding region. Archives of Biochemistry and Biophysics 324(2): 344-356, 1995

Antibodies against the extracellular domain of human Notch1 receptor reveal the critical role of epidermal-growth-factor-like repeats 25-26 in ligand binding and receptor activation. Biochemical Journal 449(2): 519-530, 2013

The extracellular domain of the epidermal growth factor receptor: Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant. European Journal of Biochemistry 225(1): 223-233, 1994

Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone). Journal of Biomolecular Structure and Dynamics 20(1): 21-29, 2002

Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process. Journal of Biomolecular Structure & Dynamics 19(6): 961-972, 2002

The ligand binding domain of the epidermal growth factor receptor is not required for receptor dimerization. Biochimica et Biophysica Acta 1134(2): 178-181, 1992

Expression and purification of the extracellular ligand-binding domain of the atrial natriuretic peptide (ANP) receptor: monovalent binding with ANP induces 2:2 complexes. Biochemistry 38(2): 516-523, 1999

The X-ray structure of a hemipteran ecdysone receptor ligand-binding domain: comparison with a lepidopteran ecdysone receptor ligand-binding domain and implications for insecticide design. Journal of Biological Chemistry 280(23): 22258-22269, 2005

Sorting of ligand-activated epidermal growth factor receptor to lysosomes requires its actin-binding domain. Journal of Biological Chemistry 279(12): 11562-9, 2004

Effects of co-expression of liver X receptor β-ligand binding domain with its partner, retinoid X receptor α-ligand binding domain, on their solubility and biological activity in Escherichia coli. Journal of Microbiology and Biotechnology 25(2): 247-254, 2015

Definition of a novel ligand binding domain of a nuclear bHLH receptor: co-localization of ligand and hsp90 binding activities within the regulable inactivation domain of the dioxin receptor. Embo Journal 12(11): 4169-4179, 1993